Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Etude de l'Incidence et Des Facteurs prédictifs de la Survenue de Fibrillation Atriale Sous Ibrutinib

NCT04407845 is registered in ClinicalTrials.gov with European Georges Pompidou Hospital as lead sponsor.

NCT NCT04407845
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04407845 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Etude de l'Incidence et Des Facteurs prédictifs de la Survenue de Fibrillation Atriale Sous Ibrutinib
Lead sponsor
European Georges Pompidou Hospital
Phase
Observational
Overall status
Unknown status
Start date
May 21, 2020
Completion date
November 30, 2022
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

leukemia, chronic lymphatic, mantle cell lymphoma